CRP and COVID-19: As displayed in Fig 3, all inflammatory biomarkers in COVID-19 patients were significantly higher in hospitalised patients than in non-hospitalised patients, e.g., CRP 59.3 mg/l (IQR 31.5–126.9) vs. 2.3 mg/l (IQR 0.9–11.1), p<0.001.